---
title: How I Treat Bleeding in Hereditary Hemorrhagic Telangiectasia
date: '2024-06-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38864625/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240613182130&v=2.18.0.post9+e462414
source: Blood
description: Hereditary hemorrhagic telangiectasia (HHT, Osler-Weber-Rendu disease)
  affects 1 in 5,000 persons, making it the second most common inherited bleeding
  disorder worldwide. Telangiectatic bleeding, primarily causing recurrent epistaxis
  and chronic gastrointestinal bleeding, is the most common and most important manifestation
  of this multisystem vascular disorder. HHT-associated bleeding results in substantial
  psychosocial morbidity and iron deficiency anemia that may be severe. Although ...
disable_comments: true
---
Hereditary hemorrhagic telangiectasia (HHT, Osler-Weber-Rendu disease) affects 1 in 5,000 persons, making it the second most common inherited bleeding disorder worldwide. Telangiectatic bleeding, primarily causing recurrent epistaxis and chronic gastrointestinal bleeding, is the most common and most important manifestation of this multisystem vascular disorder. HHT-associated bleeding results in substantial psychosocial morbidity and iron deficiency anemia that may be severe. Although ...